Cablevisión Holding Announces Its First Half and Second Quarter 2021 Results
BUENOS AIRES, ARGENTINA / ACCESSWIRE / August 10, 2021 / Cablevisión Holding S.A., (“Cablevision Holding”,…
BUENOS AIRES, ARGENTINA / ACCESSWIRE / August 10, 2021 / Cablevisión Holding S.A., (“Cablevision Holding”,…
HONOLULU, HI / ACCESSWIRE / August 10, 2021 / Pono Capital Corp (the “Company”) announced…
Acquisition Adds Cloud-Based Print Management Capabilities and Enhances Kofax’s Intelligent Automation Platform Irvine, CA –…
New relationship is set to increase Westcon-Comstor’s value to channel partners by bolstering its Zero…
Netacea research reveals the high cost of unwanted bot traffic Manchester, UK – 11th August…
London based public law and human rights practice, Rook Irwin Sweeney, has proved the value…
FLOWER MOUND, Texas., Aug. 11, 2021 /PRNewswire/ — Athletico Physical Therapy has opened a new…
MARSEILLE, France, Aug. 11, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II…
Marseille, France, Aug. 11, 2021 (GLOBE NEWSWIRE) — Pursuant to the article L. 233-8 II…
NEW YORK, Aug. 10, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (“Intercept”), a biopharmaceutical…
RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
EMERYVILLE, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA) announced today Heather…
RAMSEY, N.J. and BOCA RATON, Fla. and CONYERS, Ga., Aug. 10, 2021 (GLOBE NEWSWIRE) —…
ALLN-346 well-tolerated in recently completed Phase 1b study; first patients dosed in Phase 2a program…
CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene…
SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer…
NEWTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical…
ORIC-101 on track for initial Phase 1b data readout in prostate cancer in 2H21 ORIC-533…
– Initiated STS101 SUMMIT Phase 3 efficacy trial; topline results expected second half 2022- –…